Haya Therapeutics
Latest round
- Series A
Last raised
- May 2025
Total raised
- $90M
Investors
- 14
About Haya Therapeutics
Founded in 2019 and headquartered in Lausanne, Switzerland, Haya Therapeutics SA specializes in RNA-based therapeutics.Haya Therapeutics specializes in developing precision RNA therapies that target the human genome's dark matter, particularly focusing on long non-coding RNAs (lncRNAs). Their innovative therapeutics are designed to modulate disease-driving cell states, utilizing proprietary tools to identify diseased tissues and cells. The company aims to provide solutions for rare and chronic diseases through emerging modalities, such as engineered antisense oligonucleotides (ASOs).Haya Therapeutics generates revenue through collaborations with biopharmaceutical companies and research institutions, focusing on B2B transactions. Their revenue structures include licensing agreements, allowing partners to utilize Haya's proprietary technology in drug development. The company aims to release new products focusing on RNA-targeted therapies while expanding its market presence in North America and Europe.
Who invested in Haya Therapeutics
14 investors across 4 rounds
See all investors in Haya Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Haya Therapeutics
Who invested in Haya Therapeutics?
Haya Therapeutics has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haya Therapeutics raised?
Haya Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Haya Therapeutics last raise money?
Haya Therapeutics's most recent round on record is a Series A, in May 2025.
What does Haya Therapeutics do?
Founded in 2019 and headquartered in Lausanne, Switzerland, Haya Therapeutics SA specializes in RNA-based therapeutics.
Where is Haya Therapeutics headquartered?
Haya Therapeutics is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like Haya Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Haya Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Haya Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.